Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

FREnch Data on Outcomes in HR+/HER2- Early Breast Cancer Patients With oncotypeDX Recurrence Score-guided Therapy

NCT06185569 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Besancon as lead sponsor.

NCT NCT06185569
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06185569 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
FREnch Data on Outcomes in HR+/HER2- Early Breast Cancer Patients With oncotypeDX Recurrence Score-guided Therapy
Lead sponsor
Centre Hospitalier Universitaire de Besancon
Phase
Observational
Overall status
Recruiting
Start date
October 15, 2023
Completion date
March 31, 2029
Enrollment
4,500 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer